Used as an intermediate in the synthesis of biologically active compounds, particularly in the development of targeted protein degradation therapeutics. It serves as a key building block in the preparation of cereblon E3 ligase modulators, which are important in oncology research. Its structure enables conjugation to other pharmacophores for the design of PROTACs (proteolysis-targeting chimeras), facilitating selective degradation of disease-related proteins. Commonly employed in medicinal chemistry for optimizing drug candidates with improved stability and binding affinity.